STAR1,211.00

Strides Pharma Science Ltd.

· Pharma & Health
₹ CrorePeersSPARCSUPRIYASHILPAMEDTHYROCARERUBICONVIYASHYATHARTHPARKHOSPSMcap ₹11,162 Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
STAR
FY26
SPARC
FY26
SUPRIYA
FY25
SHILPAMED
FY26
Peer
Median
Valuation — at last close
P/E20.07×4.11×75.80×39.96× -50%
P/B3.54×4.77×7.12×5.94× -40%
EV/EBITDA13.66×4.34×43.85×24.10× -43%
Market Cap₹11,162 Cr₹6,386 Cr₹18,445 Cr₹12,416 Cr -10%
Growth
Revenue CAGR 3Y9.62%95.98%13.59%54.79% -82%
Revenue CAGR 5Y7.94%11.30%11.30% -30%
Revenue YoY (latest Q)13.01%314.11%44.90%179.50% -93%
Net Income YoY (latest Q)56.73%59.94%115.16%87.55% -35%
Profitability
EBITDA Margin19.04%85.08%28.25%56.66% -66%
Net Income Margin11.82%82.65%15.81%49.23% -76%
Return on Common Equity17.66%116.20%9.39%62.80% -72%
Return on Capital Employed17.93%112.12%11.02%61.57% -71%
Return on Assets8.29%71.55%6.57%39.06% -79%
Credit & Quality
Total Debt/Equity0.53×0.42×0.00×0.25×0.25× +112%
Interest Coverage4.05×46.54×5.36×25.95× -84%
Scale — latest FY
Revenue / Total Income₹4,859 Cr₹1,879 Cr₹1,539 Cr₹1,709 Cr +184%
Net Income₹575 Cr₹1,553 Cr₹243 Cr₹898 Cr -36%
Total Assets₹6,927 Cr₹2,171 Cr₹1,112 Cr₹3,706 Cr₹2,171 Cr +219%
EPS₹60.34₹47.86₹12.44₹30.15 +100%
Book Value per Share₹341.68₹41.26₹132.47₹86.87 +293%
◆ best value in the comp set per metric · Δ = subject vs median of the other companies.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.